Biogen(BIIB) - 2025 Q4 - Annual Results

Growth products up 6% year-over-year in the fourth quarter demonstrating continued strong commercial execution 1 Continued to deliver progress across key late-stage pipeline programs Biogen Inc. (Nasdaq: BIIB) today reported fourth quarter and full year 2025 financial results. Press Release Cambridge, Mass. – February 6, 2026 Biogen reports strong fourth quarter and full year 2025 results and provides full year 2026 financial guidance Fourth quarter 2025 total revenue $2.3 billion; GAAP diluted EPS $(0.33); ...